|
|
 |
|
Viewing report
|
|
|
|
Covidien Set to Become a Pure-play Medical Devices Company - Expected to sell its Pharmaceutical Business Unit
GlobalData, July 2011, Pages: 6
Covidien Set to Become a Pure-play Medical Devices Company - Expected to sell its Pharmaceutical Business Unit
Summary
GlobalData’s medical equipment report “Covidien Set to Become a Pure-play Medical Devices Company - Expected to sell its Pharmaceutical Business Unit” provides key insights on the rationale behind the deal. The viewpoint provides analysis and possible implications on the global medical equipment services market as a result of the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Deal overview of the rumored decision by Covidien to sell its pharmaceuticals business.
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry and on the company including analysis of the current state of Covidien’s pharmaceuticals business.
- Company profile of Covidien.
Reasons to buy
- Understand the business strategy behind deal by one of the significant medical equipment service providers by the industry.
- Explore possible repercussions on the market dynamics of medical equipment and pharmaceuticals industry.
|
|
|
|
